Company Filing History:
3 out of 41 
2 out of 62 
Years Active: 2004-2009
Title: Kohsuke Kino: Innovator in Allergy Immunotherapy
Introduction
Kohsuke Kino is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of immunotherapy, particularly in the area of allergy treatment. With a total of 5 patents, his work focuses on developing innovative solutions for patients suffering from pollen allergies.
Latest Patents
Kino's latest patents include the identification of T-cell epitope peptides from Japanese cypress (hinoki) pollen allergen molecules. This groundbreaking work involved stimulating a T-cell line established from a patient suffering from Japanese cypress pollen allergy. The identified peptide is instrumental in peptide-based immunotherapy for patients with spring tree pollinosis, including those with cross-reactivity to Japanese cypress pollen. Additionally, this peptide serves as a valuable tool for diagnosing spring tree pollinosis.
Career Highlights
Throughout his career, Kohsuke Kino has worked with prominent companies such as Meiji Dairies Corporation and Meiji Milk Products Company, Limited. His experience in these organizations has contributed to his expertise in the field of allergy research and immunotherapy.
Collaborations
Kino has collaborated with esteemed colleagues, including Kazuo Dairiki and Toshio Sone. These partnerships have further enhanced his research and development efforts in allergy treatment.
Conclusion
Kohsuke Kino's innovative work in allergy immunotherapy has the potential to significantly improve the quality of life for individuals suffering from pollen allergies. His contributions to the field are noteworthy and continue to inspire advancements in medical research.